Analytical Method Development: GC Assay Method for Volatile APIs – V 2.0
SOP for Assay Method Development of Volatile APIs Using Gas Chromatography
| Department |
Analytical Method Development |
| SOP No. |
SOP/AMD/086/2025 |
| Supersedes |
SOP/AMD/086/2022 |
| Page No. |
Page 1 of 14 |
| Issue Date |
19/05/2025 |
| Effective Date |
20/05/2025 |
| Review Date |
19/05/2026 |
1. Purpose
This SOP outlines the methodology for developing a gas chromatographic (GC) assay for volatile active pharmaceutical ingredients (APIs). It ensures accurate quantification, sensitivity,
and regulatory compliance using validated GC parameters and techniques.
2. Scope
This procedure is applicable to the Analytical Method Development (AMD) department and is intended for APIs that are volatile at ambient or elevated temperatures and require GC-based analysis for assay determination.
3. Responsibilities
- Analytical Chemist: Executes method development, sample preparation, and chromatographic analysis.
- Method Reviewer: Ensures scientific and regulatory soundness of the developed GC assay method.
- QA Officer: Verifies all documentation, calibration, and suitability checks.
- Head – AMD: Approves finalized assay method for validation and routine use.
4. Accountability
The Head of Analytical Method Development is accountable for ensuring that all GC assay methods for volatile APIs meet the validation requirements set by ICH Q2(R1) and are suitable for intended use.
5. Procedure
5.1 Selection of Analytical Technique
- Identify APIs with volatility above 40°C or vapor pressure >10 mmHg.
- Evaluate GC compatibility and select direct injection or headspace based on matrix and stability.
- Document rationale in Annexure-1: Technique Justification Log.
5.2 Instrument Configuration
- Instrument: GC with Flame Ionization Detector (FID).
- Column: DB-1 or equivalent non-polar column, 30 m × 0.25 mm ID × 0.25 µm film thickness.
- Carrier Gas: Helium at constant flow (1 mL/min).
- Oven Program: 50°C (1 min) to 250°C at 10°C/min.
- Detector and Injector Temperatures: 250°C and 220°C, respectively.
- Record in Annexure-2: GC System Setup Log.
5.3 Sample and Standard Preparation
- Standard: Prepare in DMSO, DMF, or IPA at 100% concentration level of label claim.
- Sample: Weigh accurately (e.g., 100 mg) into a 10 mL volumetric flask, add diluent, and vortex.
- If needed, analyze freshly due to evaporation risk.
- Document all preparation in Annexure-3: Sample Preparation Log.
5.4 Calibration and Linearity
- Prepare standard solutions at 50%, 80%, 100%, 120%, and 150% of target concentration.
- Inject in duplicate and plot concentration vs. peak area.
- Acceptance Criteria:
- R² ≥ 0.995
- %RSD ≤ 2% for replicate injections
- Document in Annexure-4: Linearity and Calibration Report.
5.5 Assay Calculation
- Calculate API assay using:
Assay (%) = (Area_sample / Area_standard) × (Conc_standard / Conc_sample) × 100
- Include dilution factors and response factors if applicable.
- Summarize results in Annexure-5: GC Assay Calculation Sheet.
5.6 System Suitability and Specificity
- Inject standard solution six times and calculate:
- %RSD of peak area ≤ 2%
- RT consistency (SD ≤ 0.05 min)
- Perform blank and placebo injection to ensure no interfering peaks.
- Overlay chromatograms for confirmation and record in Annexure-6: System Suitability Report.
5.7 Method Robustness
- Assess method response by varying:
- Oven ramp rate ±2°C/min
- Injector temperature ±5°C
- Split ratio (if applicable)
- Acceptance: Assay results within ±2% of original.
- Document findings in Annexure-7: Robustness Study Log.
6. Abbreviations
- API: Active Pharmaceutical Ingredient
- GC: Gas Chromatography
- FID: Flame Ionization Detector
- RT: Retention Time
- RSD: Relative Standard Deviation
- SOP: Standard Operating Procedure
7. Documents
- Technique Justification Log – Annexure-1
- GC System Setup Log – Annexure-2
- Sample Preparation Log – Annexure-3
- Linearity and Calibration Report – Annexure-4
- GC Assay Calculation Sheet – Annexure-5
- System Suitability Report – Annexure-6
- Robustness Study Log – Annexure-7
8. References
- ICH Q2(R1) – Validation of Analytical Procedures
- USP <621> – Chromatography
- USP <731> – Loss on Drying (if applicable)
- FDA Guidance – Analytical Procedures and Methods Validation
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
| Signature |
|
|
|
| Date |
|
|
|
| Name |
|
|
|
| Designation |
|
|
|
| Department |
|
|
|
11. Annexures
Annexure-1: Technique Justification Log
| API |
Boiling Point (°C) |
Justification for GC |
| Ethyl acetate |
77 |
Volatile, suitable for FID detection |
Annexure-2: GC System Setup Log
| Instrument |
Column |
Detector |
Carrier Gas |
Oven Program |
| Agilent 7890 |
DB-1, 30 m |
FID |
He |
50°C to 250°C @ 10°C/min |
Annexure-3: Sample Preparation Log
| ID |
Sample Type |
Weight (mg) |
Diluent |
Prepared By |
| API-001 |
Volatile API |
100 |
DMSO |
Rajesh Kumar |
Annexure-4: Linearity and Calibration Report
| Level (%) |
Concentration (ppm) |
Peak Area |
Status |
| 100% |
1000 |
145623 |
Pass |
Annexure-5: GC Assay Calculation Sheet
| Sample ID |
Area Sample |
Area Standard |
Result (%) |
| API-001 |
143220 |
145623 |
98.4% |
Annexure-6: System Suitability Report
| Injection No. |
Peak Area |
RT (min) |
| 1 |
145623 |
5.47 |
| 2 |
145481 |
5.46 |
Annexure-7: Robustness Study Log
| Parameter Changed |
Value |
Assay (%) |
Deviation |
| Injector Temp |
225°C |
97.8% |
-0.6% |
Revision History:
| Revision Date |
Revision No. |
Details |
Reason |
Approved By |
| 04/05/2025 |
2.0 |
Integrated assay calculation logic and robustness annexures |
Annual SOP Review |
|